Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 5, 2016, Pages 1217-1224

  Rondy, M ^a   Castilla, J ^b   Launay, O ^c   Costanzo, S ^d   Ezpeleta, C ^e   Galtier, F ^f   de Gaetano Donati, K ^g,u   Navascués, Ana ^e   Beristain, Xabier ^e   Chamorro, Judith ^e   Gabari, Mercedes ^e   Artajo, Pilar ^e   Lameiro, Francisco ^h   Barrado, Laura ^h   Ortega, Maite ⁱ   Torres, Montse ⁱ   García Irure, José Javier ⁱ   Irisarri, Fátima ^j   García Cenoz, Manuel ^j   Guevara, Marcela ^j   Casado, Itziar ^j   Díaz, Jorge ^j   Martínez Baz, Iván ^j   Castilla, Jesús ^j   Lenzi, Nezha ^k   Lesieur, Zineb ^k   Bonmarin, Isabelle ^l   Merle, Corinne ^m   Foulongne, Vincent ^m   Letois, Flavie ^m   Driss, Valérie ^m   Géraud, Philippe ^m   Bourdin, Arnaud ^m   Landreau, Liliane ^m   Konaté, Amadou ^m   Corne, Philippe ^m   Sebbane, Mustapha ^m   Klouche, Kada ^m   Léglise, Marie Suzanne ^m   Loulergue, Pierre ⁿ   Kanaan, Reem ⁿ   Dumas, Florence ⁿ   Krivine, Anne ⁿ   Moncilovic, Sonia ⁿ   Ali, Nadine ⁿ   Duval, Xavier ^o   Costa, Yolande ^o   Aït Naman, Rachid ^o   Yazdapanah, Yazdan ^o   Caseris, Marion ^o   Dournon, Nathalie ^o   Papo, Thomas ^o   Dossier, Antoine ^o   Bécheur, Hakim ^o   Pelletier, Anne Laure ^o   Mal, Hervé ^o   Marceau, Armelle ^o   Aubier, Michel ^o   Bories, Raphaêl ^o   Casalino, Enrique ^o   Choquet, Christophe ^o   Houhou, Nadhira ^o   Vanhems, Philippe ^p,q   Régis, Corinne ^p,q   Jouneau, Stéphane ^r   Lainé, Fabrice ^r   Tattevin, Pierre ^r   Beuzit, Luc ^r   Thébault, Elise ^r   Fey, Sophie ^r   Lagathu et Sophie Cha, Gisele ^r   Postil, Déborah ^s   Alcoléa, Sébastien ^s   Rogez, Sylvie ^s   Valette, Martine ^c,t   Lina, Bruno ^c,t   Cauda, Roberto ^u   Taccari, Francesco ^u   Santangelo, Rosaria ^u   Perlasca, Francesco ^v   Fichera, Giovanni ^v   Dara, Marianna ^v   Iacoviello, Licia ^d   Olivieri, Marco ^w   more..

^a Epicon0063ept   (France)

^b IdiSNA Navarra Institute for Health Research   (Spain)

^c INSERM   (France)

^d IRCCS NEUROMED   (Italy)

^e Instituto de Investigación Sanitaria de Navarra   (Spain)

^f MONTPELLIER UNIVERSITY HOSPITAL   (France)

^g CATHOLIC UNIVERSITY   (Italy)

^h HOSPITAL GARCÍA ORCOYEN   (Spain)

ⁱ Anatomía Patológica del Hospital Reina Sofía de Tudela   (Bulgaria)

^j INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^k French Clinical Vaccinology Network (Innovative clinical research network in vaccinologie (I REIVAC)   (France)

^l INSTITUT DE VEILLE SANITAIRE   (France)

^m HÔPITAL SAINT ELOI   (France)

ⁿ Hôpital Saint Eloi ^*  (France)

^o BICHAT HOSPITAL   (France)

^p EDOUARD HERRIOT HOSPITAL   (France)

^q UNIVERSITÉ LYON 1   (France)

^r PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^s DUPUYTREN UNIVERSITY HOSPITAL   (France)

^t UNIVERSITÉ DE LYON   (France)

^u FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^v OSPEDALE DI CIRCOLO   (Italy)

^w SRL   (Italy)

^x Ospedale di Circolo e Fondazione Macchi ^*  (Spain)

more..

Author keywords

case control studies; hospital; Influenza; Influenza vaccine; multicentre studies

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; ITALY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SPAIN; TREATMENT OUTCOME; VERY ELDERLY; ADOLESCENT; CLINICAL TRIAL; EUROPEAN UNION; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; OUTCOME ASSESSMENT; SEASON; SENTINEL SURVEILLANCE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VACCINATION; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EUROPEAN UNION; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SEASONS; SENTINEL SURVEILLANCE; SPAIN; VACCINATION; YOUNG ADULT;

EID: 84976415449     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1126013     Document Type: Article

References (26)

1. J.Mereckiene, S.Cotter, A.Nicoll, P.Lopalco, T.Noori, J.Weber, F.D’Ancona, D.Levy-Bruhl, L.Dematte, C.Giambi, et al. Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11). Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 2014; 19:20780; PMID:24786262
2. B.Michiels, F.Govaerts, R.Remmen, E.Vermeire, S.Coenen. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine 2011; 29:9159-70; PMID:21840359; http://dx.doi.org/10.1016/j.vaccine.2011.08.008
3. M.Saurwein-Teissl, T.L.Lung, F.Marx, C.Gschösser, E.Asch, I.Blasko, W.Parson, G.Böck, D.Schönitzer, E.Trannoy, et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(−) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol Baltim Md 1950 2002; 168:5893-9
4. K.Haq, J.E.McElhaney. Immunosenescence: Influenza vaccination and the elderly. Curr Opin Immunol 2014; 29:38-42; PMID:24769424; http://dx.doi.org/10.1016/j.coi.2014.03.008
5. T.Jefferson, C.Di Pietrantonj, L.A.Al-Ansary, E.Ferroni, S.Thorning, R.E.Thomas. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010; 17:CD004876; PMID:20166072
6. M.Rondy, J.Puig-Barbera, O.Launay, X.Duval, J.Castilla, M.Guevara, S.Costanzo, K.de Gaetano Donati, A.Moren. 2011–12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study. PloS One 2013; 8:e59681; PMID:23565159; http://dx.doi.org/10.1371/journal.pone.0059681
7. European Centre for Disease Prevention and Control. Weekly influenza surveillance overview - 23 May 2014 - Surveillance report[Internet]. Available from: http://www.ecdc.europa.eu/en/publications/Publications/influenza-surveillance-overview-23-may-2014.pdf
8. M.Valenciano, E.Kissling, B.C.Ciancio, A.Moren. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine 2010; 28:7381-8; PMID:20851086; http://dx.doi.org/10.1016/j.vaccine.2010.09.010
9. M.L.Jackson, J.C.Nelson. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31:2165-8; PMID:23499601; http://dx.doi.org/10.1016/j.vaccine.2013.02.053
10. I.M.Foppa, M.Haber, J.M.Ferdinands, D.K.Shay. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31:3104-9; PMID:23624093; http://dx.doi.org/10.1016/j.vaccine.2013.04.026
11. European Centre for Disease Prevention and Control. Influenza virus characterisation Summary Europe, July 2014[Internet]. Available from: http://ecdc.europa.eu/en/publications/Publications/influenza-characterisation-report-july-2014.pdf
12. Équipes de surveillance de la grippe. Epidemiological and virological influenza activity in mainland France: 2013–14 season (in French). BEH2014;
13. J.Castilla, I.Martínez-Baz, A.Navascués, M.Fernandez-Alonso, G.Reina, M.Guevara, J.Chamorro, M.T.Ortega, E.Albéniz, F.Pozo, et al. Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. Euro Surveillance 2014; 19(6).
14. B.F.Koel, D.F.Burke, T.M.Bestebroer, S.van der Vliet, G.C.M.Zondag, G.Vervaet, E.Skepner, N.S.Lewis, M.I.J.Spronken, C.A.Russell, et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 2013; 342:976-9; PMID:24264991; http://dx.doi.org/10.1126/science.1244730
15. G.F.Rimmelzwaan, R.A.M.Fouchier, A.D.M.E.Osterhaus. Age distribution of cases caused by different influenza viruses. Lancet Infect Dis 2013; 13:646-7; PMID:23886322; http://dx.doi.org/10.1016/S1473-3099(13)70181-6
16. K.Hancock, V.Veguilla, X.Lu, W.Zhong, E.N.Butler, H.Sun, F.Liu, L.Dong, J.R.DeVos, P.M.Gargiullo, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-52; PMID:19745214; http://dx.doi.org/10.1056/NEJMoa0906453
17. J.R.Davies, E.A.Grilli. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect 1989; 102:325-33; PMID:2703026; http://dx.doi.org/10.1017/S0950268800030004
18. D.J.Smith, S.Forrest, D.H.Ackley, A.S.Perelson. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci U S A 1999; 96:14001-6; PMID:10570188; http://dx.doi.org/10.1073/pnas.96.24.14001
19. Background Paper on Influenza Vaccines and Immunization. SAGE Working Group. 2012 [Internet]. 2013[cited 2013 Apr 19]; Available from: http://www.who.int/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf
20. T.Seyler, M.Rondy, M.Valenciano, A.Moren. Protocol for hospital-based case control studies to measure seasonal influenza vaccine effectiveness against laboratory confirmed influenza hospitalisations across the European Union and European Economic Area Member States. 2012.
21. Calendrier vaccinal et recommandations vaccinales 2013 du ministère des affaires sociales et de la santé selon l’avis du Haut Conseil de la santé publique.; 2013 vaccination schedule and recommendations from the Haut conseil de la santé publique in France.
22. Instituto de Salud Pública y Laboral de Navarra. Protocolo de vacunación antigripal 2013–2014. [Influenza vaccination protocol 2013–2014].
23. Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2013–2014. [Prevention and control of influenza: recommendations for the season 2013–2014].
24. F.MAHONEYFI, D.BARTHELDW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J 1965; 14:61-5; PMID:14258950
25. T.B.Huedo-Medina, J.Sánchez-Meca, F.Marín-Martínez, J.Botella. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11:193-206; PMID:16784338; http://dx.doi.org/10.1037/1082-989X.11.2.193
26. F.E.Harrell. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.